Prospective Pecutaneous Coronary Intervention Registry (SMC-PCI)
Status
Conditions
Treatments
Details and patient eligibility
About
Coronary artery disease is the most important cause of death worldwide. Treatment option for coronary artery disease is medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Among them, the field of percutaneous coronary intervention is rapidly developing with regard to the improvement of devices, techniques, or medical treatment, leading to reduce mortality or morbidity. Until now, numerous previous studies related to the risk factors of coronary artery disease and the prognosis of patients have been conducted. However, the field of percutaneous coronary intervention is rapidly evolving, and treatment strategies are constantly being updated. Therefore, the current study sought to identify the long-term prognosis and related risk factors of patients with coronary artery disease who underwent percutaneous coronary intervention.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- patients who have undergone or are scheduled to undergo coronary angiography and percutaneous coronary intervention.
Exclusion criteria
- patients who did not consent to the research
Trial design
15,000 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Ki Hong Choi, MD; Joo-Yong Hahn, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal